Clinical Trial Update: An Open-Label, Single-Arm Exploratory Clinical Study of Everolimus for the Treatment of Vascular Malformations [Phase 2]

View source ↗

Summary

An open-label, single-arm Phase 2 clinical study evaluating everolimus for vascular malformations; the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vascular Malformations

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: Xuanwu Hospital, Beijing | Conditions: Vascular Malformations | Phase 2 | Status: RECRUITING